Cargando…
CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion
BACKGROUND: Ovarian carcinoma (OvCa) is the most lethal gynecological malignancy among women and its poor prognosis is mainly due to metastasis. Chemokine receptor CCR9 is primarily expressed by a small subset of immune cells and its only natural ligand, CCL25, is largely expressed in the thymus, wh...
Autores principales: | Johnson, Erica L, Singh, Rajesh, Singh, Shailesh, Johnson-Holiday, Crystal M, Grizzle, William E, Partridge, Edward E, Lillard, James W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927595/ https://www.ncbi.nlm.nih.gov/pubmed/20649989 http://dx.doi.org/10.1186/1477-7819-8-62 |
Ejemplares similares
-
CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion
por: Johnson-Holiday, Crystal, et al.
Publicado: (2011) -
CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion
por: Johnson, Erica L, et al.
Publicado: (2010) -
CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis
por: Gupta, Pranav, et al.
Publicado: (2014) -
CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
por: Singh, Santosh Kumar, et al.
Publicado: (2018) -
The Roles of CCR9/CCL25 in Inflammation and Inflammation-Associated Diseases
por: Wu, Xue, et al.
Publicado: (2021)